Formus Labs News

Formus Labs Hip Platform Receives FDA Clearance!

Formus Labs today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Formus Hip as the first “automated radiological image processing software” for hip replacement pre-op planning.

Read Story
August 2, 2024

Formus Labs Adds Seasoned Medical Technology Executives Lloyd McCann and Meraj Khan to Board of Directors

Formus Labs, creator of the world's first fully-automated 3D planner for joint replacement surgeries, today announced the appointments of Mercy Radiology and Clinics CEO, Dr Lloyd McCann, and Vice President of Market Development at BK Medical, Meraj Khan, to its Board of Directors. Each brings more than 15 years of international medical technology and healthcare experience in a variety of roles.

Read Story
August 2, 2024

Formus Hip in Commercial Use

Hip-planner officially in use

Read Story
August 2, 2024

Formus Platform Successfully Exhibits at 2020’s Only Orthopedic Conference

The Formus Labs team recently returned from a successful trip exhibiting at the New Zealand Orthopaedic Association Annual Scientific Meeting, held at Te Papa in Wellington. Billed as “an extraordinary meeting in extraordinary times,” the NZOA ASM is likely to be the only orthopedic conference held globally for 2020.

Read Story
August 2, 2024

Welcoming Dr. Nicholas Giori

As we move forward with clinical evaluations, we’re delighted to add another highly respected practitioner, Nicholas Giori, M.D., Ph.D., to our clinical advisory board.

Read Story
August 2, 2024

‘Formus Spine’ Tech Demo Successfully Debuts

The Formus Labs team has recently debuted a tech demo of 'Formus Spine' at the New Zealand Orthopaedic Association (NZOA) conference held in Wellington this October. Formus Spine is currently in development as an AI-driven automated planning platform for spinal fusion surgery.

Read Story
August 2, 2024

Internationally Renowned Orthopaedic Surgeon Thought Leaders Join Formus Labs’ Clinical Advisory and Development Board.

Formus Labs, creator of the world's first automated 3D, AI-enabled pre-operative planner for joint replacement surgeries, today announces the expansion of its clinical advisory board. Three global thought leaders in the field of arthroplasty, Dr. J. Bohannon Mason, Dr. Atul Kamath and Dr. James A. Germano will help shape the next generation of Formus Labs’ innovative planning technology and will support the company’s expansion into new markets.

Read Story
August 2, 2024

Formus Labs Venture to the Valley

As a company with global ambition, a recent AANZ-sponsored trip to San Francisco served as the perfect launchpad for expanding our investor network in Silicon Valley.

Read Story
August 2, 2024

Formus Labs Team Grows to 10

Joining the Formus Labs team in newly created roles are a dedicated Product Lead, Computer Vision Engineer, and Office Administrator, bringing the total team size to 10 full-time employees.

Read Story
August 2, 2024

Formus Software Enters Clinical Evaluations

Formus Labs has begun formal clinical evaluations of its world-first personalized planning software for orthopedic surgeons.

Read Story
August 2, 2024

The Future of Orthopedic Healthcare in the Time of COVID

Formus CEO Ju Zhang on some of the challenges and opportunities facing us over the next 12 months and beyond.

Read Story
August 2, 2024

Case Study - A World-First in Knee Surgery

This recent case study, successfully completed alongside Dr. Paul Monk and the Auckland Bioengineering Institute (ABI), showcases the versatility and effectiveness of the Formus platform.

Read Story
August 2, 2024

Welcoming Dr. George Grammatopoulos

Formus Labs is pleased to announce that internationally regarded, Oxford-trained orthopaedic surgeon, Dr. George Grammatopoulos, has joined our growing clinical advisory board. Dr. Grammatopoulos will provide expert feedback on ongoing clinical evaluations and further development of Formus Labs’ AI-automated 3D pre-operative planning software.

Read Story

Subscribe for the latest news and product updates

We will never share your email address with third parties.